These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Relationships between ventricular arrhythmias and plasma concentrations of ME3202 (CM7857) in dogs. Hashimoto K, Ishii M, Watanabe K. J Cardiovasc Pharmacol; 1989 Jul; 14(1):121-6. PubMed ID: 2475703 [Abstract] [Full Text] [Related]
23. Effects of gallopamil, a Ca2+ channel blocker in models of ventricular arrhythmia in dogs. Matsuzaki T, Haruno A, Hashimoto K. Eur J Pharmacol; 1993 Feb 16; 231(3):363-70. PubMed ID: 8449229 [Abstract] [Full Text] [Related]
24. [Effects of antiarrhythmic drugs on canine ventricular arrhythmia models]. Hashimoto K. Nihon Yakurigaku Zasshi; 1989 Feb 16; 93(2):29-39. PubMed ID: 2656435 [Abstract] [Full Text] [Related]
25. Effects of dofetilide, a class III antiarrhythmic drug, on various ventricular arrhythmias in dogs. Chen J, Xue Y, Eto K, Ni C, Hashimoto K. J Cardiovasc Pharmacol; 1996 Oct 16; 28(4):576-84. PubMed ID: 8891885 [Abstract] [Full Text] [Related]
26. Antiarrhythmic effects of an aconitine-like compound, TJN-505, on canine arrhythmia models. Arita J, Xue YX, Aye NN, Fukuyama K, Wakui Y, Niitsu K, Maruno M, Siying C, Hashimoto K. Eur J Pharmacol; 1996 Dec 30; 318(2-3):333-40. PubMed ID: 9016923 [Abstract] [Full Text] [Related]
27. Antiarrhythmic effects of a novel class III drug, KCB-328, on canine ventricular arrhythmia models. Xue Y, Tanabe S, Nabuchi Y, Hashimoto K. J Cardiovasc Pharmacol; 1998 Aug 30; 32(2):239-47. PubMed ID: 9700986 [Abstract] [Full Text] [Related]
28. Acute antiarrhythmic effects of intravenously administered amiodarone on canine ventricular arrhythmia. Awaji T, Wu ZJ, Hashimoto K. J Cardiovasc Pharmacol; 1995 Dec 30; 26(6):869-78. PubMed ID: 8606522 [Abstract] [Full Text] [Related]
31. Cibenzoline. A review of its pharmacological properties and therapeutic potential in arrhythmias. Harron DW, Brogden RN, Faulds D, Fitton A. Drugs; 1992 May 30; 43(5):734-59. PubMed ID: 1379150 [Abstract] [Full Text] [Related]
32. Cibenzoline for treatment of ventricular arrhythmias: a double-blind placebo-controlled study. Kostis JB, Krieger S, Moreyra A, Cosgrove N. J Am Coll Cardiol; 1984 Aug 30; 4(2):372-7. PubMed ID: 6376595 [Abstract] [Full Text] [Related]
34. Crossover comparison of cibenzoline and quinidine in ambulatory patients with chronic ventricular arrhythmias. Mohiuddin SM, Woodruff MP, Esterbrooks DJ, Mooss AN, Hansen JM, Hilleman DE. J Cardiovasc Pharmacol; 1989 Apr 30; 13(4):525-9. PubMed ID: 2470988 [Abstract] [Full Text] [Related]
35. [Effects of N-696, a new beta-blocking agent, on canine experimental arrhythmias]. Ishii M, Komori S, Satoh H, Ohta T, Motomura S, Hashimoto K. Nihon Yakurigaku Zasshi; 1984 Sep 30; 84(3):259-66. PubMed ID: 6149986 [Abstract] [Full Text] [Related]
36. Effective plasma concentrations of antiarrhythmic drugs against sustained halothane-adrenaline arrhythmia in dogs. Shibuya T, Hashimoto K, Imai S. J Cardiovasc Pharmacol; 1983 Sep 30; 5(4):538-45. PubMed ID: 6193348 [Abstract] [Full Text] [Related]
37. Antiarrhythmic effects of bisaramil on triggered arrhythmias produced by intracoronary injection of digitalis and adrenaline in the dog. Haruno A, Hashimoto K. Jpn J Pharmacol; 1995 May 30; 68(1):95-102. PubMed ID: 7494388 [Abstract] [Full Text] [Related]
39. Effects of a new antiarrhythmic drug, SD-3212, on canine ventricular arrhythmia models. Hirasawa A, Haruno A, Matsuzaki T, Hashimoto K. Jpn Heart J; 1992 Nov 30; 33(6):851-61. PubMed ID: 1299746 [Abstract] [Full Text] [Related]
40. Antiarrhythmic properties of a prior oral loading of amiodarone in in vivo canine coronary ligation/reperfusion-induced arrhythmia model: comparison with other class III antiarrhythmic drugs. Nagasawa Y, Chen J, Hashimoto K. J Pharmacol Sci; 2005 Mar 30; 97(3):393-9. PubMed ID: 15764841 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]